Advanced search
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
LAMOTTE, M, Lieven Annemans, A LEFEVER, M NECHELPUT, and J MASURE. 2001. “Orlistat in Obese Type 2 Diabetic Patients: Assessment of Long Term Outcomes and Costeffectiveness.” In Podium Presentation at the ISPOR 4th Annual European Conference. Cannes 11- 14/11/2001, Proceedings in Value in Health, 2001, Vol.4 (5).
APA
LAMOTTE, M., Annemans, L., LEFEVER, A., NECHELPUT, M., & MASURE, J. (2001). Orlistat in obese type 2 diabetic patients: assessment of long term outcomes and costeffectiveness. Podium presentation at the ISPOR 4th annual European Conference. Cannes 11- 14/11/2001, proceedings in Value in health, 2001, Vol.4 (5).
Vancouver
1.
LAMOTTE M, Annemans L, LEFEVER A, NECHELPUT M, MASURE J. Orlistat in obese type 2 diabetic patients: assessment of long term outcomes and costeffectiveness. Podium presentation at the ISPOR 4th annual European Conference. Cannes 11- 14/11/2001, proceedings in Value in health, 2001, Vol.4 (5). 2001.
MLA
LAMOTTE, M, Lieven Annemans, A LEFEVER, et al. “Orlistat in Obese Type 2 Diabetic Patients: Assessment of Long Term Outcomes and Costeffectiveness.” Podium Presentation at the ISPOR 4th Annual European Conference. Cannes 11- 14/11/2001, Proceedings in Value in Health, 2001, Vol.4 (5). 2001. Print.
@inproceedings{142312,
  author       = {LAMOTTE, M and Annemans, Lieven and LEFEVER, A and NECHELPUT, M and MASURE, J},
  booktitle    = {Podium presentation at the ISPOR 4th annual European Conference. Cannes 11- 14/11/2001, proceedings in Value in health, 2001, Vol.4 (5)},
  language     = {eng},
  title        = {Orlistat in obese type 2 diabetic patients: assessment of long term outcomes and costeffectiveness},
  year         = {2001},
}